Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
1,557 JPY | +0.71% | +2.44% | +9.50% |
18/04 | Nxera Pharma Initiates Restricted Stock Unit Plans, Starting with Shares Worth 164 Million Yen in Total in May | MT |
17/04 | Nxera Pharma's Neuro Drug NBI-1117568 Passed Preclinical Toxicity Test | MT |
- Stock Market
- Equities
- 4565 Stock
- News Nxera Pharma Co., Ltd.
- Analyst Reco.